Elon Musk认为,抑制食欲的药物Semaglutide可以解决美国肥胖症上升的问题。 Elon Musk suggests appetite-inhibiting drug Semaglutide could address rising US obesity.

科技企业家埃隆·马斯克表示,新的抑制食欲的药物,如Semaglutide (诺沃诺迪斯克公司以Ozempic和Wegovy的名称销售) 可能有助于对抗美国肥胖率的上升. Tech entrepreneur Elon Musk suggests new appetite-inhibiting drugs like Semaglutide (marketed as Ozempic and Wegovy by Novo Nordisk) could help combat rising obesity levels in the US. 这种药物最初用于2型糖尿病,通过模仿GLP-1荷尔蒙、减少饥饿和使人们感到更充分,可以帮助减轻体重。 The drug, initially for type 2 diabetes, is found to aid weight loss by mimicking GLP-1 hormone, reducing hunger, and making people feel fuller. 据Musk说,这些药物可以大大减少肥胖率。 According to Musk, these drugs could significantly reduce obesity rates.